Results of combined therapy for maxillary sinus squamous cell carcinoma

Yamada Shoko, Onodera Shu, Yahara Katsuya, Ohguri Takayuki, Kato Fumio, Nomoto Satoshi, Imada Hajime, Nakata Hajime, Terashima Hiromi, Kudoh Koji, Yoshida Masafumi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The results of 54 cases of maxillary sinus squamous cell carcinoma treated between 1980 and 2002 were analyzed retrospectively. The T classification according to the 1997 UICC was as follows: 2 with stage T1, 29 with T3, and 23 with T4. Ten patients (18.5 %) had lymph node metastases at diagnosis. All patients underwent combined therapy including radiotherapy surgery, and regional or systemic chemotherapy. Fifteen patients received hyperfractionated twice-daily radiotherapy (1.2 Gy or 1.5 Gy/fraction), and the remaining 39 patients received a conventional once-daily regimen (1.5-2 Gy/fraction). The 5-year overall survival and 5-year disease-free survival for all patients were 56.0% and 46.7%, respectively. The N classification was the only significant prognostic factor for 5-year disease-free survival by univariate analysis (favoring N=0, p=0.04). There were no significant differences in other prognostic factors including gender, T classification (T1-3 vs. T4), hyperfractionated radiotherapy (yes vs. no), total dose (BED: <69 Gy 10 vs. ≧69 Gy10), and intra-arterial chemotherapy (yes vs. no). Although radiation-induced cataract was observed in 9 patients, no other severe late complications developed.

Original languageEnglish
Pages (from-to)316-321
Number of pages6
JournalNippon Acta Radiologica
Volume63
Issue number6
Publication statusPublished - Jul 25 2003

Fingerprint

Maxillary Sinus
Squamous Cell Carcinoma
Radiotherapy
Disease-Free Survival
Therapeutics
Drug Therapy
Survival Analysis
Cataract
Lymph Nodes
Radiation
Neoplasm Metastasis
Survival

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

Shoko, Y., Shu, O., Katsuya, Y., Takayuki, O., Fumio, K., Satoshi, N., ... Masafumi, Y. (2003). Results of combined therapy for maxillary sinus squamous cell carcinoma. Nippon Acta Radiologica, 63(6), 316-321.

Results of combined therapy for maxillary sinus squamous cell carcinoma. / Shoko, Yamada; Shu, Onodera; Katsuya, Yahara; Takayuki, Ohguri; Fumio, Kato; Satoshi, Nomoto; Hajime, Imada; Hajime, Nakata; Hiromi, Terashima; Koji, Kudoh; Masafumi, Yoshida.

In: Nippon Acta Radiologica, Vol. 63, No. 6, 25.07.2003, p. 316-321.

Research output: Contribution to journalArticle

Shoko, Y, Shu, O, Katsuya, Y, Takayuki, O, Fumio, K, Satoshi, N, Hajime, I, Hajime, N, Hiromi, T, Koji, K & Masafumi, Y 2003, 'Results of combined therapy for maxillary sinus squamous cell carcinoma', Nippon Acta Radiologica, vol. 63, no. 6, pp. 316-321.
Shoko Y, Shu O, Katsuya Y, Takayuki O, Fumio K, Satoshi N et al. Results of combined therapy for maxillary sinus squamous cell carcinoma. Nippon Acta Radiologica. 2003 Jul 25;63(6):316-321.
Shoko, Yamada ; Shu, Onodera ; Katsuya, Yahara ; Takayuki, Ohguri ; Fumio, Kato ; Satoshi, Nomoto ; Hajime, Imada ; Hajime, Nakata ; Hiromi, Terashima ; Koji, Kudoh ; Masafumi, Yoshida. / Results of combined therapy for maxillary sinus squamous cell carcinoma. In: Nippon Acta Radiologica. 2003 ; Vol. 63, No. 6. pp. 316-321.
@article{ae75b6270124457cb40b232d171aa941,
title = "Results of combined therapy for maxillary sinus squamous cell carcinoma",
abstract = "The results of 54 cases of maxillary sinus squamous cell carcinoma treated between 1980 and 2002 were analyzed retrospectively. The T classification according to the 1997 UICC was as follows: 2 with stage T1, 29 with T3, and 23 with T4. Ten patients (18.5 {\%}) had lymph node metastases at diagnosis. All patients underwent combined therapy including radiotherapy surgery, and regional or systemic chemotherapy. Fifteen patients received hyperfractionated twice-daily radiotherapy (1.2 Gy or 1.5 Gy/fraction), and the remaining 39 patients received a conventional once-daily regimen (1.5-2 Gy/fraction). The 5-year overall survival and 5-year disease-free survival for all patients were 56.0{\%} and 46.7{\%}, respectively. The N classification was the only significant prognostic factor for 5-year disease-free survival by univariate analysis (favoring N=0, p=0.04). There were no significant differences in other prognostic factors including gender, T classification (T1-3 vs. T4), hyperfractionated radiotherapy (yes vs. no), total dose (BED: <69 Gy 10 vs. ≧69 Gy10), and intra-arterial chemotherapy (yes vs. no). Although radiation-induced cataract was observed in 9 patients, no other severe late complications developed.",
author = "Yamada Shoko and Onodera Shu and Yahara Katsuya and Ohguri Takayuki and Kato Fumio and Nomoto Satoshi and Imada Hajime and Nakata Hajime and Terashima Hiromi and Kudoh Koji and Yoshida Masafumi",
year = "2003",
month = "7",
day = "25",
language = "English",
volume = "63",
pages = "316--321",
journal = "Nippon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica",
issn = "0048-0428",
publisher = "Japan Radiological Society",
number = "6",

}

TY - JOUR

T1 - Results of combined therapy for maxillary sinus squamous cell carcinoma

AU - Shoko, Yamada

AU - Shu, Onodera

AU - Katsuya, Yahara

AU - Takayuki, Ohguri

AU - Fumio, Kato

AU - Satoshi, Nomoto

AU - Hajime, Imada

AU - Hajime, Nakata

AU - Hiromi, Terashima

AU - Koji, Kudoh

AU - Masafumi, Yoshida

PY - 2003/7/25

Y1 - 2003/7/25

N2 - The results of 54 cases of maxillary sinus squamous cell carcinoma treated between 1980 and 2002 were analyzed retrospectively. The T classification according to the 1997 UICC was as follows: 2 with stage T1, 29 with T3, and 23 with T4. Ten patients (18.5 %) had lymph node metastases at diagnosis. All patients underwent combined therapy including radiotherapy surgery, and regional or systemic chemotherapy. Fifteen patients received hyperfractionated twice-daily radiotherapy (1.2 Gy or 1.5 Gy/fraction), and the remaining 39 patients received a conventional once-daily regimen (1.5-2 Gy/fraction). The 5-year overall survival and 5-year disease-free survival for all patients were 56.0% and 46.7%, respectively. The N classification was the only significant prognostic factor for 5-year disease-free survival by univariate analysis (favoring N=0, p=0.04). There were no significant differences in other prognostic factors including gender, T classification (T1-3 vs. T4), hyperfractionated radiotherapy (yes vs. no), total dose (BED: <69 Gy 10 vs. ≧69 Gy10), and intra-arterial chemotherapy (yes vs. no). Although radiation-induced cataract was observed in 9 patients, no other severe late complications developed.

AB - The results of 54 cases of maxillary sinus squamous cell carcinoma treated between 1980 and 2002 were analyzed retrospectively. The T classification according to the 1997 UICC was as follows: 2 with stage T1, 29 with T3, and 23 with T4. Ten patients (18.5 %) had lymph node metastases at diagnosis. All patients underwent combined therapy including radiotherapy surgery, and regional or systemic chemotherapy. Fifteen patients received hyperfractionated twice-daily radiotherapy (1.2 Gy or 1.5 Gy/fraction), and the remaining 39 patients received a conventional once-daily regimen (1.5-2 Gy/fraction). The 5-year overall survival and 5-year disease-free survival for all patients were 56.0% and 46.7%, respectively. The N classification was the only significant prognostic factor for 5-year disease-free survival by univariate analysis (favoring N=0, p=0.04). There were no significant differences in other prognostic factors including gender, T classification (T1-3 vs. T4), hyperfractionated radiotherapy (yes vs. no), total dose (BED: <69 Gy 10 vs. ≧69 Gy10), and intra-arterial chemotherapy (yes vs. no). Although radiation-induced cataract was observed in 9 patients, no other severe late complications developed.

UR - http://www.scopus.com/inward/record.url?scp=0141834166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141834166&partnerID=8YFLogxK

M3 - Article

C2 - 12934550

AN - SCOPUS:0141834166

VL - 63

SP - 316

EP - 321

JO - Nippon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica

JF - Nippon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica

SN - 0048-0428

IS - 6

ER -